Question: A 63-year-old woman with a 6-year history of fibrostenotic ileocolonic Crohn’s disease (CD) presented for evaluation after multiple hospitalizations for recurrent small bowel obstruction (SBO). Treatment for CD included adalimumab and azathioprine. Before initiation of these medications, she had undergone a 30-cm ileal resection for partial SBO secondary to a fibroinflammatory ileal stricture. She had no other coexistent medical conditions. She denied nonsteroidal antiinflammatory drug use, but did take acetaminophen for intermittent low back pain.